Type I IFN Signaling Protects Mice from Lethal SARS-CoV-2 Neuroinvasion

Keyphrases

• IFN-I 100%
• Type I IFN Signaling 100%
• SARS-CoV-2 Neuroinvasion 100%
• Receptor Signaling 60%
• SARS-CoV-2 Infection 40%
• IFN-I Signaling 40%
• Virus 20%
• Viral Replication 20%
• Lethality 20%
• Infection Site 20%
• Lung 20%
• Pathogenic Mechanism 20%
• Viral Clearance 20%
• Host Immune Response 20%
• Transgenic Mouse Model 20%
• Infectious Virus 20%
• Pathological Manifestations 20%
• Primary Infection 20%
• Type I IFN 20%
• COVID-19 20%
• Neuroinvasion 20%
• Multiple Organ Damage 20%
• Acute Lethality 20%
• Acute Viral Infection 20%
• Antiviral Role 20%
• COVID-19 Severity 20%
• K18-hACE2 Mice 20%
• Severe COVID-19 20%
• Adaptive Phase 20%

Medicine and Dentistry

• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Receptor 75%
• Infection 50%
• COVID-19 50%
• Lethality 50%
• In Vitro 25%
• Antivirus Agent 25%
• Virus Infection 25%
• Virus Infectivity 25%
• Immune Response 25%
• Transgenic Mouse 25%
• Virus Replication 25%
• Primary Infection 25%
• Viral Clearance 25%
• Lung 25%
• Virus 25%

Immunology and Microbiology

• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Infection 75%
• COVID-19 50%
• Viral Disease 25%
• Virus Infectivity 25%
• Mouse Model 25%
• Viral Replication 25%
• Transgenic Mouse 25%
• Viral Clearance 25%
• Host Immune Response 25%
• Virus 25%
• In Vitro 25%